date,title,source
Oct-17-18,5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage,InvestorPlace
Oct-17-18,"Report: Exploring Fundamental Drivers Behind Bellicum Pharmaceuticals, Social Reality, Exelixis, Edgewell Personal Care, Cronos Group, and Acacia Communications  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-18-18,"Exelixis to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018",Business Wire
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-22-18,Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in Combination with Atezolizumab in Previously Untreated Advanced Renal Cell Carcinoma,Business Wire
